https://doi.org/10.1056/nejmoa050434
T
Tanja Fehm
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2.0K
Papers
34.5K
Citations
83
h-index
452
i10-index
Tanja Fehm is an academic researcher from Düsseldorf University Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Cells and Metastasis & Cancer Genomics and Diagnostics. The author has an h-index of 83, co-authored 1664 publications.
ORCID: 0000-0002-4926-0108Papers by this author
worksA Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
2005 · New England Journal of Medicine · 1,375 citations
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
2009 · Breast Cancer Research · 729 citations
https://doi.org/10.1186/bcr2333
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
2012 · New England Journal of Medicine · 530 citations
https://doi.org/10.1056/nejmoa1111065
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
2023 · The Lancet · 322 citations
https://doi.org/10.1016/s0140-6736(23)00725-0
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
2009 · Breast Cancer Research · 240 citations
https://doi.org/10.1186/bcr2349
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
2012 · Cancer and Metastasis Reviews · 235 citations
https://doi.org/10.1007/s10555-012-9398-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat